InvestorsHub Logo

AgentSmith

03/16/19 2:22 PM

#24712 RE: damAcon1 #24711

I am treating this stock as a pharmaceutical stock. Like most pharmaceutical stocks their stock does nothing until clinical trials and/or FDA approval.

Looks like they - Lexaria & Altria - figure that initiative is going to take about three years or so.



In other news: Seems we should expect to see ChrgD+ on the shelves in a couple weeks!